Alan R. Saltiel

Alan R. Saltiel was the Mary Sue Coleman Director of the Life Sciences Institute at the University of Michigan; a professor at the Division of Molecular Medicine and Genetics at the University of Michigan Medical School; a faculty member at the Michigan Diabetes Research and Training Center; and John Jacob Abel Professor of Life Sciences, Department of Molecular and Integrative Physiology; a member of the Steering Committee Member at the Center for Advancing Research & Solutions for Society.[1] He served as the Director of the Life Sciences Institute from 2001 to 2015.[2] He was also a John Jacob Abel Collegiate Professor of the Life Sciences at the Department of Molecular & Integrative Physiology at the UM Medical School.[3] He holds an AB from Duke University (1975) and a Ph.D. from the University of North Carolina (1980).[4]

Alan Saltiel has been the director of the University of Michigan Life Sciences Institute since 2001

During his doctorate studies in biochemistry at the University of North Carolina, Saltiel worked on thyroid-stimulating hormone and its relationship to thyroid cancer. As a post-doctoral fellow under Pedro Cuatrecasas in the Wellcome Research Labs, he began investigating insulin. He was Distinguished Research Fellow and Senior Director of the Department of Cell Biology at Parke-Davis Pharmaceutical Research Division (now Pfizer Global Research). In addition to having published more than 260 research papers, Saltiel holds 16 patents and has extensive experience with the FDA's testing and approval process for new drugs.

Saltiel's lab researches signaling pathways in insulin action.[5] Such research is aimed at identifying the various ways in which problems with the insulin signaling pathway trigger diabetes.[6] Researchers in the lab have also uncovered new hormone signaling pathways and the role that proteins and genes play in this process.[6] These discoveries may reveal how the insulin-glucose balance necessary for the survival of the cell is lost due to obesity in those with diabetes.[1][6]

Awards and achievements

Saltiel has received many awards over the course of his career, including the Rosalyn Yalow Research and Development Award from the American Diabetes Association, Hirschl Award, The John Jacob Abel Award from ASPET and The Goodman and Gilman Award, also from ASPET.[7] He is a member of the Institute of Medicine and fellow of the American Association for the Advancement of Science. His work is often cited in biochemistry literature;[7] with more than 35,000 citations as of February 2014, he ranks among the most influential scientists in biology and biochemistry in the world.[8]

His true dream is to star for the New York Knicks.[9]

References
  1. "Alan Saltiel Elected to Institute of Medicine-Medicine at Michigan Fall 2005". Archived from the original on 2008-02-23. Retrieved 2007-12-17.
  2. "Saltiel Lab - Affiliations | Life Sciences at Michigan here". Archived from the original on 2011-05-29. Retrieved 2007-12-17.
  3. University of Michigan
  4. "Saltiel Lab - Faculty - Curriculum Vitae | Life Sciences at Michigan here". Archived from the original on 2008-11-19. Retrieved 2007-12-17.
  5. In Diabetes, a Complex of Causes - New York Times
  6. "University of Michigan: Diabetes at U of M". Archived from the original on 2008-01-24. Retrieved 2007-12-17.
  7. Access to articles : Nature Reviews Drug Discovery
  8. Highly Cited Research
  9. "Archived copy". Archived from the original on 2009-02-14. Retrieved 2008-12-09.CS1 maint: archived copy as title (link)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.